QUICKHEAL

Quick Heal Technologies Limited

Cybersecurity solutions under Quick Heal and Seqrite brands

Information Technology›Information Technology›IT - Software›Software Products

quickheal.co.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹148.68
Market cap
807 Cr
Stock P/E
Loss (TTM EPS ₹-1.90)
P/B
1.85
Dividend yield
2.0%
ROE (FY26)
-2.5%
ROCE (FY26)
-4.7%
Operating margin (FY26)
-16.6%
Debt / equity (FY26)
0.00

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Quick Heal sells cybersecurity software, from antivirus for individual users under the Quick Heal brand to endpoint, network and data protection for businesses and government under the Seqrite brand, and is based in Pune.

Company snapshot

10thBy market cap

Ranked among 14 companies in Software Products.

What we see

Positives
  • ✓Debt-to-equity of 0.00x — the company is largely funded by its own money, not borrowed funds.
Concerns
  • ✗Net margin is negative — the company is spending more than it earns right now.
2 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales78 Cr82 Cr80 Cr70 Cr73 Cr71 Cr65 Cr57 Cr84 Cr72 Cr49 Cr45 Cr
Operating expenses (approx.)67 Cr70 Cr70 Cr68 Cr70 Cr74 Cr74 Cr67 Cr74 Cr71 Cr78 Cr63 Cr
EBITDA11 Cr12 Cr10 Cr3 Cr3 Cr-4 Cr-8 Cr-10 Cr9 Cr0.45 Cr-29 Cr-18 Cr
OPM %14.0%14.2%12.5%3.7%4.2%-5.3%-13.0%-17.0%11.1%0.6%-60.2%-39.1%
Other income6 Cr4 Cr7 Cr5 Cr5 Cr5 Cr6 Cr6 Cr4 Cr9 Cr4 Cr14 Cr
Interest0 Cr0 Cr0.13 Cr0.05 Cr0.05 Cr0.06 Cr0.06 Cr0.06 Cr0.05 Cr0.06 Cr0.03 Cr0 Cr
Depreciation3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr4 Cr3 Cr3 Cr4 Cr4 Cr4 Cr
Profit before tax13 Cr13 Cr14 Cr5 Cr5 Cr-2 Cr-7 Cr-7 Cr10 Cr6 Cr-30 Cr-7 Cr
Tax %3.8%19.7%-3.6%16.2%18.1%104.8%50.5%21.3%23.1%-15.0%32.8%27.9%
Net profit13 Cr10 Cr14 Cr4 Cr4 Cr0.11 Cr-3 Cr-6 Cr8 Cr7 Cr-20 Cr-5 Cr
EPS (₹)₹2.43₹1.89₹2.63₹0.75₹0.77₹0.02₹-0.60₹-1.00₹1.43₹1.19₹-3.58₹-0.94

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales300 Cr318 Cr315 Cr286 Cr333 Cr342 Cr278 Cr292 Cr280 Cr261 CrSign in free for the trailing twelve months
Operating expenses (approx.)214 Cr198 Cr187 Cr195 Cr192 Cr235 Cr276 Cr274 Cr286 Cr290 CrSign in free for the trailing twelve months
EBITDA86 Cr120 Cr128 Cr91 Cr141 Cr107 Cr2 Cr18 Cr-7 Cr-29 CrSign in free for the trailing twelve months
OPM %28.8%37.8%40.6%31.9%42.5%31.3%0.7%6.0%-2.4%-11.3%Sign in free for the trailing twelve months
Other income28 Cr30 Cr33 Cr32 Cr24 Cr19 Cr22 Cr21 Cr21 Cr23 CrSign in free for the trailing twelve months
Interest—0 Cr—0 Cr0 Cr0 Cr0 Cr0.13 Cr0.22 Cr0.20 CrSign in free for the trailing twelve months
Depreciation31 Cr27 Cr24 Cr22 Cr19 Cr17 Cr16 Cr13 Cr13 Cr14 CrSign in free for the trailing twelve months
Profit before tax84 Cr123 Cr137 Cr101 Cr146 Cr109 Cr8 Cr26 Cr1 Cr-21 CrSign in free for the trailing twelve months
Tax %36.5%32.7%33.0%26.6%26.8%23.5%20.2%7.5%-404.0%47.0%Sign in free for the trailing twelve months
Net profit53 Cr83 Cr92 Cr74 Cr107 Cr83 Cr6 Cr24 Cr5 Cr-11 CrSign in free for the trailing twelve months
EPS (₹)₹7.60₹11.82₹13.03₹11.34₹16.66₹14.01₹1.14₹4.56₹0.94₹-1.98Sign in free for the trailing twelve months
Dividend payout %————-0.0%27.8%407.7%54.8%320.0%—Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital70 Cr70 Cr71 Cr64 Cr64 Cr58 Cr53 Cr54 Cr54 Cr54 Cr
Reserves592 Cr653 Cr719 Cr580 Cr687 Cr570 Cr367 Cr383 Cr387 Cr382 Cr
Borrowings——————————
Other liabilities72 Cr57 Cr63 Cr52 Cr75 Cr88 Cr74 Cr76 Cr84 Cr110 Cr
Total liabilities734 Cr781 Cr853 Cr697 Cr827 Cr716 Cr493 Cr513 Cr525 Cr547 Cr
Fixed assets (net)178 Cr161 Cr157 Cr149 Cr140 Cr106 Cr98 Cr84 Cr83 Cr89 Cr
CWIP14 Cr14 Cr11 Cr3 Cr2 Cr0 Cr0 Cr3 Cr0.05 Cr0 Cr
Investments182 Cr306 Cr390 Cr310 Cr416 Cr343 Cr222 Cr222 Cr214 Cr237 Cr
Loans & advances———0.77 Cr0.68 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Inventories8 Cr6 Cr5 Cr6 Cr3 Cr5 Cr5 Cr3 Cr2 Cr3 Cr
Trade receivables97 Cr103 Cr125 Cr113 Cr151 Cr172 Cr123 Cr132 Cr167 Cr138 Cr
Cash & bank59 Cr12 Cr13 Cr10 Cr16 Cr8 Cr12 Cr38 Cr21 Cr13 Cr
Other assets196 Cr178 Cr152 Cr105 Cr98 Cr82 Cr35 Cr32 Cr37 Cr68 Cr
Total assets734 Cr781 Cr853 Cr697 Cr827 Cr716 Cr493 Cr513 Cr525 Cr547 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity36 Cr94 Cr61 Cr71 Cr130 Cr127 Cr31 Cr18 Cr-22 Cr15 Cr
Cash from investing-73 Cr-122 Cr-37 Cr148 Cr-124 Cr79 Cr185 Cr6 Cr16 Cr-26 Cr
Cash from financing-20 Cr-19 Cr-24 Cr-221 Cr0.10 Cr-214 Cr-212 Cr2 Cr-10 Cr3 Cr
Net cash flow-57 Cr-47 Cr0.55 Cr-3 Cr6 Cr-9 Cr4 Cr26 Cr-17 Cr-8 Cr
Free cash flow (OCF − Capex)1 Cr80 Cr51 Cr59 Cr121 Cr121 Cr27 Cr11 Cr-37 Cr-0.03 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %12.7%17.0%17.3%15.7%19.4%17.3%1.9%6.0%0.3%-4.7%
ROE %8.0%11.5%11.6%11.6%14.2%13.3%1.5%5.5%1.1%-2.5%
Debtor days118118145144165183161165217192
Inventory days1487172964427911182172614762493132206
Days payable7661100554627173231771323516159413550320843277
Cash conversion cycle-6056-8208-3839-14387-16367-21606-14304-32845-1735-2879
OCF / EBITDA %41.5%78.0%48.0%77.2%92.1%118.7%n.m.103.7%——
OCF / EBITDA % (3 years)——57.1%66.5%72.7%96.4%115.1%139.2%n.m.—
Debt / equity———0.000.000.000.000.000.000.00
Current ratio7.1110.3710.699.898.676.204.504.964.723.40
Net debt / EBITDA-0.69—-0.10-0.11-0.12-0.07-6.16-2.14——